TABLE 8.
Group mean | SD | Significance vs placeboa | ||
---|---|---|---|---|
EPA (n = 33) | EPAb | 0.49 | 0.50 | NS |
DHAb | 7.59 | 3.82 | NS | |
Total omega-3 highly unsaturated fatty acidsc | 25.12 | 7.22 | NS | |
DHA (n = 33) | EPAb | 0.43 | 0.34 | NS |
DHAb | 9.94 | 4.82 | < .05 | |
Total omega-3 highly unsaturated fatty acidsc | 29.87 | 7.04 | < .05 | |
Placebo (n = 36) | EPAb | 0.50 | 0.49 | — |
DHAb | 6.23 | 2.58 | — | |
Total omega-3 highly unsaturated fatty acidsc | 22.44 | 7.03 | — |
ANOVA, analysis of variance; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; NS, not significant; SD, standard deviation.
One-way ANOVA with Tukey’s multiple comparison test;
Expressed as percent of total fatty acids;
Expressed as percent of total highly unsaturated fatty acids.